Drug: Ivonescimab Injection
SMT112-3005
Phase 3 small_molecule active
Quick answer
Drug: Ivonescimab Injection for Metastatic Colorectal Cancer (CRC) is a Phase 3 program (small_molecule) at Summit Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Summit Therapeutics
- Indication
- Metastatic Colorectal Cancer (CRC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active